Inactive Ingredient Search for Approved Drug Products
Search Names Beginning with L
Inactive Ingredient | Route | Dosage Form | CAS Number | UNII | Maximum Potency per unit dose | Maximum Daily Exposure (MDE) | Record Updated |
---|---|---|---|---|---|---|---|
LACTIC ACID | INTRACARDIAC | INJECTION | 33X04XA5AT | 0.01%w/v | |||
LACTIC ACID | INTRAMUSCULAR | INJECTION | 33X04XA5AT | 1.16%w/v | |||
LACTIC ACID | INTRAMUSCULAR | INJECTION, SOLUTION | 33X04XA5AT | 3mg | |||
LACTIC ACID | INTRAMUSCULAR | SOLUTION | 33X04XA5AT | ADJ PH | |||
LACTIC ACID | INTRAVENOUS | INJECTION | 33X04XA5AT | 2232mg | |||
LACTIC ACID | INTRAVENOUS | INJECTION, SOLUTION | 33X04XA5AT | 3mg | |||
LACTIC ACID | ORAL | CAPSULE | 33X04XA5AT | 6mg | |||
LACTIC ACID | ORAL | CAPSULE, LIQUID FILLED | 33X04XA5AT | 44mg | |||
LACTIC ACID | ORAL | CONCENTRATE | 33X04XA5AT | 50mg/5ml | |||
LACTIC ACID | ORAL | SOLUTION | 33X04XA5AT | 192mg | |||
LACTIC ACID | ORAL | TABLET | 33X04XA5AT | ADJ PH | |||
LACTIC ACID | SUBCUTANEOUS | INJECTION | 33X04XA5AT | 10mg | |||
LACTIC ACID | TOPICAL | AEROSOL | 33X04XA5AT | 1.05%w/w | |||
LACTIC ACID | TOPICAL | AEROSOL, FOAM | 33X04XA5AT | 1.05%w/w | |||
LACTIC ACID | TOPICAL | CREAM | 33X04XA5AT | 1%w/w | |||
LACTIC ACID | TOPICAL | GEL | 33X04XA5AT | 30mg | |||
LACTIC ACID | TOPICAL | LOTION | 33X04XA5AT | 5.7%w/w | |||
LACTIC ACID | TOPICAL | OINTMENT | 33X04XA5AT | ADJ PH | |||
LACTIC ACID | TOPICAL | SOLUTION | 33X04XA5AT | 7.22%w/w | |||
LACTIC ACID | TOPICAL | SUSPENSION | 33X04XA5AT | 0.7%w/w | |||
LACTIC ACID | VAGINAL | CREAM | 33X04XA5AT | 0.81%w/w | |||
LACTIC ACID | VAGINAL | SUPPOSITORY | 33X04XA5AT | NA | |||
LACTIC ACID, DL- | INTRAMUSCULAR | INJECTION | 50215 | 3B8D35Y7S4 | ADJ PH | ||
LACTIC ACID, DL- | INTRAMUSCULAR | INJECTION, SOLUTION | 50215 | 3B8D35Y7S4 | ADJ PH | ||
LACTIC ACID, DL- | INTRAVENOUS | INJECTION | 50215 | 3B8D35Y7S4 | 5.64%w/v | ||
LACTIC ACID, DL- | INTRAVENOUS | INJECTION, SOLUTION | 50215 | 3B8D35Y7S4 | ADJ PH | Y | |
LACTIC ACID, DL- | ORAL | CAPSULE | 50215 | 3B8D35Y7S4 | 127mg | ||
LACTIC ACID, DL- | ORAL | LIQUID | 50215 | 3B8D35Y7S4 | 10mg/5ml | ||
LACTIC ACID, DL- | ORAL | SYRUP | 50215 | 3B8D35Y7S4 | 25mg | ||
LACTIC ACID, DL- | SUBCUTANEOUS | PELLET, IMPLANTABLE | 50215 | 3B8D35Y7S4 | NA | ||
LACTIC ACID, DL- | TOPICAL | CREAM | 50215 | 3B8D35Y7S4 | 0.45%w/w | Y | |
LACTIC ACID, DL- | TOPICAL | GEL | 50215 | 3B8D35Y7S4 | 3.65%w/w | Y | |
LACTIC ACID, DL- | TOPICAL | SOLUTION | 50215 | 3B8D35Y7S4 | 7.4%w/w | ||
LACTIC ACID, DL- | VAGINAL | JELLY | 50215 | 3B8D35Y7S4 | 3.1%w/w | ||
LACTIC ACID, DL- | VAGINAL | SUPPOSITORY | 50215 | 3B8D35Y7S4 | NA | ||
LACTIC ACID, L- | AURICULAR (OTIC) | SOLUTION/ DROPS | 79334 | F9S9FFU82N | ADJ PH | Y | |
LACTIC ACID, L- | INTRAMUSCULAR | INJECTION | 79334 | F9S9FFU82N | ADJ PH | Y | |
LACTIC ACID, L- | INTRAVENOUS | INJECTION | 79334 | F9S9FFU82N | 51mg | Y | |
LACTIC ACID, L- | ORAL | CAPSULE | 79334 | F9S9FFU82N | 132mg | ||
LACTIC ACID, L- | ORAL | SOLUTION | 79334 | F9S9FFU82N | 88mg | Y | |
LACTIC ACID, L- | SUBCUTANEOUS | INJECTION | 79334 | F9S9FFU82N | 51mg | Y | |
LACTIC ACID, L- | TOPICAL | AEROSOL, FOAM | 79334 | F9S9FFU82N | 1%w/w | Y | |
LACTIC ACID, L- | TOPICAL | CREAM | 79334 | F9S9FFU82N | 0.44%w/w | Y | |
LACTIC ACID, L- | VAGINAL | CREAM | 79334 | F9S9FFU82N | ADJ PH | Y | |
LACTITOL MONOHYDRATE | ORAL | CAPSULE | 81025049 | UH2K6W1Y64 | 235mg | ||
LACTOBIONIC ACID | INTRAVENOUS | INJECTION | 96822 | 65R938S4DV | 956mg | ||
LACTOBIONIC ACID | INTRAVENOUS | INJECTION, POWDER, FOR SOLUTION | 96822 | 65R938S4DV | ADJ PH | ||
LACTOSE | BUCCAL | TABLET | J2B2A4N98G | 296.7mg | |||
LACTOSE | INTRACAVITARY | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | J2B2A4N98G | 193.8mg | |||
LACTOSE | INTRAMUSCULAR | INJECTION | J2B2A4N98G | 203.5mg | |||
LACTOSE | INTRAMUSCULAR | INJECTION, POWDER, FOR SOLUTION | J2B2A4N98G | 133mg | |||
LACTOSE | INTRAVENOUS | INJECTION | J2B2A4N98G | 203.5mg | |||
LACTOSE | INTRAVENOUS | INJECTION, POWDER, FOR SOLUTION | J2B2A4N98G | 133mg | |||
LACTOSE | INTRAVENOUS | INJECTION, SOLUTION | J2B2A4N98G | 0.45%w/v | |||
LACTOSE | ORAL | CAPSULE | J2B2A4N98G | 530mg | |||
LACTOSE | ORAL | CAPSULE, COATED PELLETS | J2B2A4N98G | 135.2mg | |||
LACTOSE | ORAL | CAPSULE, COATED, EXTENDED RELEASE | J2B2A4N98G | NA | |||
LACTOSE | ORAL | CAPSULE, DELAYED RELEASE | J2B2A4N98G | 231.84mg | |||
LACTOSE | ORAL | CAPSULE, EXTENDED RELEASE | J2B2A4N98G | 120mg | |||
LACTOSE | ORAL | CONCENTRATE | J2B2A4N98G | NA | |||
LACTOSE | ORAL | GRANULE, FOR SUSPENSION | J2B2A4N98G | 512.5mg/5ml | |||
LACTOSE | ORAL | POWDER, FOR SOLUTION | J2B2A4N98G | NA | |||
LACTOSE | ORAL | SOLUTION | J2B2A4N98G | 1682mg/15ml | |||
LACTOSE | ORAL | TABLET | J2B2A4N98G | 2500mg | |||
LACTOSE | ORAL | TABLET, CHEWABLE | J2B2A4N98G | 1412mg | |||
LACTOSE | ORAL | TABLET, COATED | J2B2A4N98G | 332.05mg | |||
LACTOSE | ORAL | TABLET, DELAYED RELEASE | J2B2A4N98G | 458mg | |||
LACTOSE | ORAL | TABLET, EFFERVESCENT | J2B2A4N98G | 96.5mg | |||
LACTOSE | ORAL | TABLET, EXTENDED RELEASE | J2B2A4N98G | 400mg | |||
LACTOSE | ORAL | TABLET, FILM COATED | J2B2A4N98G | 590mg | |||
LACTOSE | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | J2B2A4N98G | 620mg | |||
LACTOSE | ORAL | TABLET, SUGAR COATED | J2B2A4N98G | NA | |||
LACTOSE | RECTAL | SOLUTION | J2B2A4N98G | 8%w/v | |||
LACTOSE | RECTAL | TABLET | J2B2A4N98G | 20mg | |||
LACTOSE | RESPIRATORY (INHALATION) | CAPSULE | J2B2A4N98G | 44.4mg | |||
LACTOSE | RESPIRATORY (INHALATION) | POWDER | J2B2A4N98G | 90mg | |||
LACTOSE | SUBCUTANEOUS | INJECTION, POWDER, FOR SOLUTION | J2B2A4N98G | 133mg | |||
LACTOSE | SUBLINGUAL | TABLET | J2B2A4N98G | 352mg | |||
LACTOSE | TOPICAL | OINTMENT | J2B2A4N98G | NA | |||
LACTOSE | TRANSDERMAL | FILM, EXTENDED RELEASE | J2B2A4N98G | 675mg | |||
LACTOSE | VAGINAL | CREAM | J2B2A4N98G | 3%w/w | |||
LACTOSE | VAGINAL | INSERT | J2B2A4N98G | 696mg | Y | ||
LACTOSE | VAGINAL | POWDER | J2B2A4N98G | 430mg | |||
LACTOSE | VAGINAL | SUPPOSITORY | J2B2A4N98G | NA | |||
LACTOSE MONOHYDRATE | BUCCAL | TABLET | 64044515 | EWQ57Q8I5X | 43mg | ||
LACTOSE MONOHYDRATE | INTRACAVITARY | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 64044515 | EWQ57Q8I5X | 47.5mg | ||
LACTOSE MONOHYDRATE | INTRAMUSCULAR | INJECTION | 64044515 | EWQ57Q8I5X | 150mg | ||
LACTOSE MONOHYDRATE | INTRAMUSCULAR | INJECTION, POWDER, FOR SOLUTION | 64044515 | EWQ57Q8I5X | 214mg | ||
LACTOSE MONOHYDRATE | INTRAMUSCULAR | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 64044515 | EWQ57Q8I5X | 150mg | ||
LACTOSE MONOHYDRATE | INTRAVENOUS | INJECTION | 64044515 | EWQ57Q8I5X | 900mg | ||
LACTOSE MONOHYDRATE | INTRAVENOUS | INJECTION, POWDER, FOR SOLUTION | 64044515 | EWQ57Q8I5X | 750mg | ||
LACTOSE MONOHYDRATE | INTRAVENOUS | INJECTION, POWDER, FOR SUSPENSION | 64044515 | EWQ57Q8I5X | 9.5%w/v | ||
LACTOSE MONOHYDRATE | INTRAVENOUS | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 64044515 | EWQ57Q8I5X | 690mg | ||
LACTOSE MONOHYDRATE | ORAL | CAPSULE | 64044515 | EWQ57Q8I5X | 3990mg | ||
LACTOSE MONOHYDRATE | ORAL | CAPSULE, COATED | 64044515 | EWQ57Q8I5X | 300mg | ||
LACTOSE MONOHYDRATE | ORAL | CAPSULE, COATED PELLETS | 64044515 | EWQ57Q8I5X | 265mg | ||
LACTOSE MONOHYDRATE | ORAL | CAPSULE, DELAYED RELEASE | 64044515 | EWQ57Q8I5X | 458mg | ||
LACTOSE MONOHYDRATE | ORAL | CAPSULE, EXTENDED RELEASE | 64044515 | EWQ57Q8I5X | 5364mg | ||
LACTOSE MONOHYDRATE | ORAL | GRANULE | 64044515 | EWQ57Q8I5X | 8946mg | ||
LACTOSE MONOHYDRATE | ORAL | GRANULE, FOR SOLUTION | 64044515 | EWQ57Q8I5X | 1691.8mg/120ml | ||
LACTOSE MONOHYDRATE | ORAL | GRANULE, FOR SUSPENSION | 64044515 | EWQ57Q8I5X | NA | ||
LACTOSE MONOHYDRATE | ORAL | INHALANT | 64044515 | EWQ57Q8I5X | NA | ||
LACTOSE MONOHYDRATE | ORAL | PELLET | 64044515 | EWQ57Q8I5X | 640mg | ||
LACTOSE MONOHYDRATE | ORAL | POWDER | 64044515 | EWQ57Q8I5X | 50mg | ||
LACTOSE MONOHYDRATE | ORAL | POWDER, FOR SUSPENSION | 64044515 | EWQ57Q8I5X | NA | ||
LACTOSE MONOHYDRATE | ORAL | TABLET | 64044515 | EWQ57Q8I5X | 4384mg | ||
LACTOSE MONOHYDRATE | ORAL | TABLET, CHEWABLE | 64044515 | EWQ57Q8I5X | 1184mg | ||
LACTOSE MONOHYDRATE | ORAL | TABLET, COATED | 64044515 | EWQ57Q8I5X | 1301mg | ||
LACTOSE MONOHYDRATE | ORAL | TABLET, DELAYED RELEASE | 64044515 | EWQ57Q8I5X | 2313mg | ||
LACTOSE MONOHYDRATE | ORAL | TABLET, EXTENDED RELEASE | 64044515 | EWQ57Q8I5X | 2575mg | ||
LACTOSE MONOHYDRATE | ORAL | TABLET, FILM COATED | 64044515 | EWQ57Q8I5X | 1056mg | ||
LACTOSE MONOHYDRATE | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 64044515 | EWQ57Q8I5X | 520mg | ||
LACTOSE MONOHYDRATE | ORAL | TABLET, FOR SUSPENSION | 64044515 | EWQ57Q8I5X | 2794mg | ||
LACTOSE MONOHYDRATE | ORAL | TABLET, ORALLY DISINTEGRATING | 64044515 | EWQ57Q8I5X | 366mg | ||
LACTOSE MONOHYDRATE | RESPIRATORY (INHALATION) | POWDER | 64044515 | EWQ57Q8I5X | 25mg | ||
LACTOSE MONOHYDRATE | SUBCUTANEOUS | INJECTION | 64044515 | EWQ57Q8I5X | 49mg | ||
LACTOSE MONOHYDRATE | SUBCUTANEOUS | INJECTION, POWDER, FOR SOLUTION | 64044515 | EWQ57Q8I5X | 214mg | ||
LACTOSE MONOHYDRATE | SUBCUTANEOUS | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 64044515 | EWQ57Q8I5X | 107mg | ||
LACTOSE MONOHYDRATE | SUBLINGUAL | TABLET | 64044515 | EWQ57Q8I5X | 505mg | ||
LACTOSE MONOHYDRATE | VAGINAL | CREAM | 64044515 | EWQ57Q8I5X | 586mg | Y | |
LACTOSE MONOHYDRATE | VAGINAL | INSERT | 64044515 | EWQ57Q8I5X | 630mg | ||
LACTOSE MONOHYDRATE - CELLULOSE, MICROCRYSTALLINE | ORAL | TABLET | NA | 614.2mg | |||
LACTOSE MONOHYDRATE - CELLULOSE, MICROCRYSTALLINE | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | NA | 121.5mg | |||
LANETH | TOPICAL | CREAM | 8051965 | NA | 0.4%w/w | ||
LANETH | TOPICAL | LIQUID | 8051965 | NA | 5.5%w/w | ||
LANETH | TOPICAL | SOAP | 8051965 | NA | 0.5%w/w | ||
LANETH | TOPICAL | SOLUTION | 8051965 | NA | 0.5%w/w | ||
LANOLIN | NASAL | SPRAY | 8006540 | 7EV65EAW6H | NA | ||
LANOLIN | OPHTHALMIC | OINTMENT | 8006540 | 7EV65EAW6H | 3%w/w | ||
LANOLIN | RECTAL | OINTMENT | 8006540 | 7EV65EAW6H | 105mg | ||
LANOLIN | TOPICAL | CREAM | 8006540 | 7EV65EAW6H | 3%w/w | ||
LANOLIN | TOPICAL | EMULSION | 8006540 | 7EV65EAW6H | 0.25%w/w | ||
LANOLIN | TOPICAL | LOTION | 8006540 | 7EV65EAW6H | 1.5%w/w | ||
LANOLIN | TOPICAL | OINTMENT | 8006540 | 7EV65EAW6H | 10%w/w | ||
LANOLIN | TOPICAL | SHAMPOO | 8006540 | 7EV65EAW6H | 2%w/w | ||
LANOLIN | VAGINAL | CREAM | 8006540 | 7EV65EAW6H | 2%w/w | ||
LANOLIN ALCOHOL - MINERAL OIL | TOPICAL | CREAM | NA | 5%w/w | |||
LANOLIN ALCOHOL - MINERAL OIL | TOPICAL | LOTION | NA | 11%w/w | |||
LANOLIN ALCOHOLS | OPHTHALMIC | OINTMENT | 8027336 | 884C3FA9HE | 10%w/w | ||
LANOLIN ALCOHOLS | TOPICAL | CREAM | 8027336 | 884C3FA9HE | 6%w/w | ||
LANOLIN ALCOHOLS | TOPICAL | LOTION | 8027336 | 884C3FA9HE | 9360mg | ||
LANOLIN ALCOHOLS | TOPICAL | OINTMENT | 8027336 | 884C3FA9HE | 452mg | ||
LANOLIN CHOLESTEROLS | TOPICAL | EMULSION | NA | NA | |||
LANOLIN CHOLESTEROLS | TOPICAL | SPONGE | NA | NA | |||
LANOLIN OIL | OPHTHALMIC | OINTMENT | 70321630 | OVV5IIJ58F | 3%w/w | ||
LANOLIN OIL | TOPICAL | CREAM | 70321630 | OVV5IIJ58F | 143mg | ||
LANOLIN, ETHOXYLATED | TOPICAL | SOLUTION | 61790816 | NA | 1.5%w/w | ||
LANOSTEROL | TOPICAL | CREAM | 79630 | 1J05Z83K3M | NA | ||
LAURAMINE OXIDE | TOPICAL | SOLUTION | 1643205 | 4F6FC4MI8W | 3.5%w/v | ||
LAURAMINE OXIDE | TOPICAL | SPONGE | 1643205 | 4F6FC4MI8W | NA | ||
LAURETH SULFATE | TOPICAL | SPONGE | NA | 20%w/w | |||
LAURETH-2 | TOPICAL | SHAMPOO | 3055934 | D4D38LT1L5 | 2%w/w | ||
LAURETH-23 | TOPICAL | AEROSOL | 9002920 | N72LMW566G | 0.45%w/w | ||
LAURETH-23 | TOPICAL | AEROSOL, FOAM | 9002920 | N72LMW566G | 1.08%w/w | ||
LAURETH-23 | TOPICAL | CREAM | 9002920 | N72LMW566G | NA | ||
LAURETH-23 | TOPICAL | EMULSION | 9002920 | N72LMW566G | 0.45%w/w | ||
LAURETH-23 | TOPICAL | LOTION | 9002920 | N72LMW566G | NA | ||
LAURETH-4 | TOPICAL | CREAM | 9002920 | 6HQ855798J | 1.1%w/w | ||
LAURETH-4 | TOPICAL | GEL | 9002920 | 6HQ855798J | 60mg | ||
LAURETH-4 | TOPICAL | LOTION | 9002920 | 6HQ855798J | 1.3%w/w | ||
LAURETH-4 | TOPICAL | SOLUTION | 9002920 | 6HQ855798J | 5.22%w/v | ||
LAURIC DIETHANOLAMIDE | TOPICAL | EMULSION | 120401 | I29I2VHG38 | 15%w/w | ||
LAURIC DIETHANOLAMIDE | TOPICAL | LOTION | 120401 | I29I2VHG38 | 0.6%w/v | ||
LAURIC DIETHANOLAMIDE | TOPICAL | SHAMPOO | 120401 | I29I2VHG38 | 20%w/w | ||
LAURIC DIETHANOLAMIDE | TOPICAL | SHAMPOO, SUSPENSION | 120401 | I29I2VHG38 | 4%w/v | ||
LAURIC DIETHANOLAMIDE | TOPICAL | SPONGE | 120401 | I29I2VHG38 | 5%w/w | ||
LAURIC DIETHANOLAMIDE | TOPICAL | SUSPENSION | 120401 | I29I2VHG38 | 0.48%w/w | ||
LAURIC MYRISTIC MONOETHANOLAMIDE | TOPICAL | EMULSION | NA | 1.1%w/w | |||
LAURIC MYRISTIC MONOETHANOLAMIDE | TOPICAL | SHAMPOO | NA | 4%w/w | |||
LAURIC/MYRISTIC DIETHANOLOLAMIDE | TOPICAL | EMULSION | 97926108 | KB1BQB7R06 | NA | ||
LAURIC/MYRISTIC DIETHANOLOLAMIDE | TOPICAL | SPONGE | 97926108 | KB1BQB7R06 | NA | ||
LAUROYL PEG-32 GLYCERIDES | ORAL | CAPSULE | 121548047 | H5ZC52369M | 7200mg | ||
LAUROYL PEG-32 GLYCERIDES | ORAL | TABLET | 121548047 | H5ZC52369M | 0.15mg | ||
LAUROYL POLYOXYLGLYCERIDES | ORAL | CAPSULE | NA | 218mg | |||
LAUROYL POLYOXYLGLYCERIDES | ORAL | TABLET | NA | 0.15mg | |||
LAUROYL POLYOXYLGLYCERIDES | ORAL | TABLET, FILM COATED | NA | 0.15mg | |||
LAURYL LACTATE | TRANSDERMAL | FILM, EXTENDED RELEASE | 6283927 | G5SU0BFK7O | 12mg | ||
LAURYL SULFATE | ORAL | CAPSULE | 151417 | DIQ16UC154 | 0.15mg | ||
LAURYL SULFATE | ORAL | TABLET, FILM COATED | 151417 | DIQ16UC154 | 2mg | ||
LAVENDER OIL | NASAL | INHALANT | 8000280 | ZBP1YXW0H8 | NA | ||
LAVENDER OIL | TOPICAL | GEL | 8000280 | ZBP1YXW0H8 | 0.1%w/w | ||
LECITHIN | INTRAMUSCULAR | INJECTION | 8002435 | NA | 0.6%w/v | ||
LECITHIN | ORAL | CAPSULE | 8002435 | NA | 15mg | ||
LECITHIN | ORAL | CAPSULE, EXTENDED RELEASE | 8002435 | NA | NA | ||
LECITHIN | ORAL | CAPSULE, LIQUID FILLED | 8002435 | NA | 3900mg | ||
LECITHIN | ORAL | POWDER, FOR SUSPENSION | 8002435 | NA | 167mg/5ml | ||
LECITHIN | ORAL | SUSPENSION | 8002435 | NA | 150mg | ||
LECITHIN | ORAL | TABLET | 8002435 | NA | 40mg | ||
LECITHIN | ORAL | TABLET, DELAYED RELEASE | 8002435 | NA | 1mg | ||
LECITHIN | ORAL | TABLET, EXTENDED RELEASE | 8002435 | NA | 10mg | ||
LECITHIN | ORAL | TABLET, FILM COATED | 8002435 | NA | 2mg | ||
LECITHIN | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 8002435 | NA | 0.14mg | ||
LECITHIN | RECTAL | SUPPOSITORY | 8002435 | NA | 6.5mg | ||
LECITHIN | TOPICAL | GEL | 8002435 | NA | 1%w/w | ||
LECITHIN | TOPICAL | SOLUTION | 8002435 | NA | 1.4%w/w | ||
LECITHIN | VAGINAL | CREAM | 8002435 | NA | 1%w/w | ||
LEMON OIL, COLD PRESSED | DENTAL | PASTE, DENTIFRICE | 8008568 | I9GRO824LL | 0.7%w/w | ||
LEMON OIL, COLD PRESSED | ORAL | CAPSULE | 8008568 | I9GRO824LL | 8.5mg | ||
LEMON OIL, COLD PRESSED | ORAL | SUSPENSION | 8008568 | I9GRO824LL | 1mg | ||
LEMON OIL, COLD PRESSED | TOPICAL | GEL | 8008568 | I9GRO824LL | 0.05%w/w | ||
LEMON TINCTURE | ORAL | SYRUP | 8028384 | NA | 0.5mg/1ml | ||
LEUCINE | INTRAVENOUS | INJECTION | 61905 | GMW67QNF9C | 1.1%w/v | ||
LEUCINE | INTRAVENOUS | INJECTION, SOLUTION | 61905 | GMW67QNF9C | 0.27%w/v | ||
LEUCINE | ORAL | CAPSULE | 61905 | GMW67QNF9C | 1mg | ||
LEUCINE | ORAL | TABLET | 61905 | GMW67QNF9C | 4.5mg | ||
LEVOMENTHOL | BUCCAL | GUM, CHEWING | 2216515 | BZ1R15MTK7 | 113mg | ||
LEVOMENTHOL | ORAL | SOLUTION | 2216515 | BZ1R15MTK7 | 15mg | ||
LEVOMENTHOL | ORAL | SUSPENSION | 2216515 | BZ1R15MTK7 | 1mg | Y | |
LEVOMENTHOL | ORAL | TABLET | 2216515 | BZ1R15MTK7 | 5mg | ||
LEVOMENTHOL | ORAL | TABLET, ORALLY DISINTEGRATING | 2216515 | BZ1R15MTK7 | 1mg | ||
LEVOMENTHOL | SUBLINGUAL | SPRAY | 2216515 | BZ1R15MTK7 | 0.05mg/1ml | ||
LEVOMENTHOL | TOPICAL | LOTION | 2216515 | BZ1R15MTK7 | 0.08%w/w | ||
LEVOMENTHOL | TOPICAL | SOLUTION | 2216515 | BZ1R15MTK7 | 0.08%w/v | Y | |
LEVOMENTHOL | TOPICAL | SPRAY | 2216515 | BZ1R15MTK7 | 2mg | ||
LEVULINIC ACID | TRANSDERMAL | FILM, EXTENDED RELEASE | 123762 | RYX5QG61EI | 16.5mg | ||
LEVULINIC ACID | TRANSDERMAL | SYSTEM | 123762 | RYX5QG61EI | 20mg | ||
LIGHT GREEN CF YELLOWISH | ORAL | CAPSULE | 6546185 | K414AX1M5S | 40mg | ||
LIGHT GREEN CF YELLOWISH | ORAL | TABLET | 6546185 | K414AX1M5S | NA | ||
LIGHT GREEN SF YELLOWISH | ORAL | TABLET | 5141208 | 3F7BHA64Z0 | 0.05mg | ||
LIGHT GREEN SF YELLOWISH | ORAL | TABLET, EXTENDED RELEASE | 5141208 | 3F7BHA64Z0 | 0.59mg | ||
LIGHT MINERAL OIL | AURICULAR (OTIC) | OIL | 92062356 | N6K5787QVP | 43.44%v/v | ||
LIGHT MINERAL OIL | DENTAL | PASTE | 92062356 | N6K5787QVP | 45.8%w/w | ||
LIGHT MINERAL OIL | ORAL | CAPSULE | 92062356 | N6K5787QVP | 0.8mg | ||
LIGHT MINERAL OIL | ORAL | PASTILLE | 92062356 | N6K5787QVP | 3.6mg | ||
LIGHT MINERAL OIL | ORAL | TABLET | 92062356 | N6K5787QVP | 7.5mg | ||
LIGHT MINERAL OIL | ORAL | TABLET, COATED | 92062356 | N6K5787QVP | 4.8mg | ||
LIGHT MINERAL OIL | ORAL | TABLET, EXTENDED RELEASE | 92062356 | N6K5787QVP | 1mg | ||
LIGHT MINERAL OIL | ORAL | TABLET, FILM COATED | 92062356 | N6K5787QVP | 2.49mg | ||
LIGHT MINERAL OIL | TOPICAL | AEROSOL, FOAM | 92062356 | N6K5787QVP | 240mg | Y | |
LIGHT MINERAL OIL | TOPICAL | CREAM | 92062356 | N6K5787QVP | 456mg | ||
LIGHT MINERAL OIL | TOPICAL | CREAM, AUGMENTED | 92062356 | N6K5787QVP | 25%w/w | ||
LIGHT MINERAL OIL | TOPICAL | EMULSION | 92062356 | N6K5787QVP | 5%w/w | ||
LIGHT MINERAL OIL | TOPICAL | GEL | 92062356 | N6K5787QVP | 20mg | ||
LIGHT MINERAL OIL | TOPICAL | LOTION | 92062356 | N6K5787QVP | 48000mg | Y | |
LIGHT MINERAL OIL | TOPICAL | OIL | 92062356 | N6K5787QVP | 2509mg | ||
LIGHT MINERAL OIL | TOPICAL | OINTMENT | 92062356 | N6K5787QVP | 1335mg | ||
LIGHT MINERAL OIL | TOPICAL | SOLUTION/ DROPS | 92062356 | N6K5787QVP | 36.95%w/v | ||
LIGHT MINERAL OIL | TRANSDERMAL | FILM, EXTENDED RELEASE | 92062356 | N6K5787QVP | 162mg | ||
LIGHT MINERAL OIL | TRANSDERMAL | SYSTEM | 92062356 | N6K5787QVP | 170mg | ||
LIGHT MINERAL OIL | VAGINAL | SUPPOSITORY | 92062356 | N6K5787QVP | 1464.9mg | ||
LIME (CALCIUM OXIDE) | ORAL | CAPSULE | 1305788 | C7X2M0VVNH | NA | ||
LIME (CALCIUM OXIDE) | ORAL | SOLUTION, CONCENTRATE | 1305788 | C7X2M0VVNH | 0.1ml/1ml | ||
LIME OIL, COLD PRESSED | ORAL | LOZENGE | 8008262 | UZH29XGA8G | 10mg | ||
LIME OIL, COLD PRESSED | SUBLINGUAL | TABLET | 8008262 | UZH29XGA8G | NA | ||
LIMONENE, (+)- | ORAL | TABLET, ORALLY DISINTEGRATING | 5989275 | GFD7C86Q1W | 1mg | ||
LIMONENE, (+)- | TOPICAL | GEL | 5989275 | GFD7C86Q1W | 0.5%w/w | ||
LIMONENE, (+)- | TOPICAL | LOTION | 5989275 | GFD7C86Q1W | 10%v/v | ||
LINEAR TRIDECYL BENZENE SULFONATE | TOPICAL | SOAP | NA | 0.05%w/w | |||
LIQUID PETROLEUM | TOPICAL | LIQUID | 8002059 | 6ZAE7X688J | 5%w/w | ||
LIQUID PETROLEUM | TOPICAL | OINTMENT | 8002059 | 6ZAE7X688J | 97.48%w/w | ||
LOCUST BEAN GUM | ORAL | TABLET, EXTENDED RELEASE | 9000402 | V4716MY704 | 74.25mg | ||
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE | ORAL | CAPSULE | 9004642 | 2165RE0K14 | 150mg | ||
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE | ORAL | TABLET | 9004642 | 2165RE0K14 | 480mg | ||
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE | ORAL | TABLET, DELAYED RELEASE | 9004642 | 2165RE0K14 | 103mg | ||
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE | ORAL | TABLET, FILM COATED | 9004642 | 2165RE0K14 | 40mg | ||
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (11% HYDROXYPROPYL; 100000 MW) | ORAL | CAPSULE, DELAYED RELEASE | 9004642 | BMJ7J4127K | 65mg | ||
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (11% HYDROXYPROPYL; 100000 MW) | ORAL | CAPSULE, EXTENDED RELEASE | 9004642 | BMJ7J4127K | 141mg | ||
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (11% HYDROXYPROPYL; 100000 MW) | ORAL | TABLET | 9004642 | BMJ7J4127K | 54mg | ||
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (11% HYDROXYPROPYL; 120000 MW) | ORAL | CAPSULE | 9004642 | NZ94SDL6WR | 178mg | ||
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (11% HYDROXYPROPYL; 120000 MW) | ORAL | CAPSULE, DELAYED RELEASE | 9004642 | NZ94SDL6WR | 40mg | ||
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (11% HYDROXYPROPYL; 120000 MW) | ORAL | TABLET | 9004642 | NZ94SDL6WR | 370mg | ||
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (11% HYDROXYPROPYL; 120000 MW) | ORAL | TABLET, CHEWABLE | 9004642 | NZ94SDL6WR | 70mg | ||
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (11% HYDROXYPROPYL; 120000 MW) | ORAL | TABLET, DELAYED RELEASE | 9004642 | NZ94SDL6WR | 84mg | ||
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (11% HYDROXYPROPYL; 120000 MW) | ORAL | TABLET, EXTENDED RELEASE | 9004642 | NZ94SDL6WR | 13mg | ||
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (11% HYDROXYPROPYL; 120000 MW) | ORAL | TABLET, FILM COATED | 9004642 | NZ94SDL6WR | 210mg | ||
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (11% HYDROXYPROPYL; 120000 MW) | ORAL | TABLET, ORALLY DISINTEGRATING | 9004642 | NZ94SDL6WR | 60mg | ||
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (11% HYDROXYPROPYL; 130000 MW) | ORAL | CAPSULE | 9004642 | 7773C1ROEU | 200mg | ||
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (11% HYDROXYPROPYL; 130000 MW) | ORAL | CAPSULE, EXTENDED RELEASE | 9004642 | 7773C1ROEU | 16.25mg | ||
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (11% HYDROXYPROPYL; 130000 MW) | ORAL | TABLET | 9004642 | 7773C1ROEU | 512mg | ||
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (11% HYDROXYPROPYL; 130000 MW) | ORAL | TABLET, CHEWABLE | 9004642 | 7773C1ROEU | 48mg | ||
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (11% HYDROXYPROPYL; 130000 MW) | ORAL | TABLET, DELAYED RELEASE | 9004642 | 7773C1ROEU | 180mg | ||
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (11% HYDROXYPROPYL; 130000 MW) | ORAL | TABLET, DELAYED RELEASE PARTICLES | 9004642 | 7773C1ROEU | 30mg | ||
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (11% HYDROXYPROPYL; 130000 MW) | ORAL | TABLET, FILM COATED | 9004642 | 7773C1ROEU | 50mg | ||
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (11% HYDROXYPROPYL; 130000 MW) | ORAL | TABLET, FOR SUSPENSION | 9004642 | 7773C1ROEU | 320mg | ||
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (11% HYDROXYPROPYL; 130000 MW) | ORAL | TABLET, ORALLY DISINTEGRATING | 9004642 | 7773C1ROEU | 60mg | ||
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (11% HYDROXYPROPYL; 140000 MW) | ORAL | TABLET | 599BTP6K9F | 50mg | |||
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (8% HYDROXYPROPYL: 140000 MW) | ORAL | TABLET | 9004642 | U466TXA0AK | 54mg | ||
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (8% HYDROXYPROPYL; 120000 MW) | ORAL | CAPSULE, EXTENDED RELEASE | 9004642 | R67D5N7LRS | 194mg | ||
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE (8% HYDROXYPROPYL; 120000 MW) | ORAL | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE | 9004642 | R67D5N7LRS | 120mg | ||
LUDIPRESS | ORAL | TABLET | NA | 80mg | |||
LUDIPRESS | ORAL | TABLET, EXTENDED RELEASE | NA | 58mg | |||
LYSINE | INTRAMUSCULAR | INJECTION | 56871 | K3Z4F929H6 | NA | ||
LYSINE | INTRAVENOUS | INJECTION | 56871 | K3Z4F929H6 | 0.61%w/v | ||
LYSINE | INTRAVENOUS | INJECTION, SOLUTION | 56871 | K3Z4F929H6 | 0.22%w/v | ||
LYSINE ACETATE | INTRAVENOUS | INJECTION | 57282492 | TTL6G7LIWZ | 7.56mg | ||
LYSINE ACETATE | INTRAVENOUS | INJECTION, SOLUTION | 57282492 | TTL6G7LIWZ | 0.31%w/v | ||
LYSINE HYDROCHLORIDE | INTRAVENOUS | INJECTION, SOLUTION | 657272 | JNJ23Q2COM | 5040mg | ||
LYSINE MONOHYDRATE | INTRAVENOUS | INJECTION | 39665128 | F7625B974U | 0.8%w/v |
FDA/Center for Drug Evaluation and Research
Office of Pharmaceutical Quality
Office of Policy for Pharmaceutical Quality
Mailbox for IID corrections: IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly
Data Through: July 3, 2024
Database Last Updated: July 31, 2024